activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1790367	CHEMBL856393	Percent residual activity, relative to control, of ERK8 at 1 uM concentration of inhibitor in presence of 5 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL413460	=	Activity	%	52.0	CHEMBL5198	Homo sapiens	Activity	%	52.0
	1790367	CHEMBL856393	Percent residual activity, relative to control, of ERK8 at 1 uM concentration of inhibitor in presence of 5 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL413460	=	Activity	%	52.0	CHEMBL5198	Homo sapiens	Activity	%	52.0
	1790421	CHEMBL856393	Percent residual activity, relative to control, of ERK8 at 1 uM concentration of inhibitor in presence of 5 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL279185	=	Activity	%	50.0	CHEMBL5198	Homo sapiens	Activity	%	50.0
	2077658	CHEMBL945011	Residual activity of ERK8 at 10 uM relative to control	B	O=c1[nH]c2ccccc2c(-c2ccncc2)c1-c1ccc(F)cc1		CHEMBL434737	=	Activity	%	73.0	CHEMBL5198	Homo sapiens	Activity	%	73.0
	2077661	CHEMBL945011	Residual activity of ERK8 at 10 uM relative to control	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	84.0	CHEMBL5198	Homo sapiens	Activity	%	84.0
	2077662	CHEMBL945011	Residual activity of ERK8 at 10 uM relative to control	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	88.0	CHEMBL5198	Homo sapiens	Activity	%	88.0
	2101318	CHEMBL949029	Inhibition of ERK8 at 10 uM	B	CC(C)(C)CN1CCC(NC(=O)c2csc(NC(=O)c3ccc4cc5n(c4c3)C3(CCC3)CNC5=O)n2)CC1		CHEMBL257834	=	Inhibition	%	82.0	CHEMBL5198	Homo sapiens	Inhibition	%	82.0
Not Active	2302185	CHEMBL950854	Inhibition of ERK8 at 10 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL5198	Homo sapiens	INH		
	2470216	CHEMBL983618	Inhibition of ERK8 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5198	Homo sapiens	INH	%	10.0
	2635187	CHEMBL1000625	Inhibition of ERK8 at 1 uM relative to control	B	CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL496009	=	Residual_activity	%	100.0	CHEMBL5198	Homo sapiens	Residual_activity	%	100.0
	2635930	CHEMBL1000625	Inhibition of ERK8 at 1 uM relative to control	B	O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12		CHEMBL498112	=	Residual_activity	%	100.0	CHEMBL5198	Homo sapiens	Residual_activity	%	100.0
	2635998	CHEMBL1000625	Inhibition of ERK8 at 1 uM relative to control	B	CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1		CHEMBL496073	<	Residual_activity	%	25.0	CHEMBL5198	Homo sapiens	Residual_activity	%	25.0
Antagonist	2902121	CHEMBL1061212	Percentage ERK8 activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	40.0	CHEMBL5198	Homo sapiens	Activity	%	40.0
	2902122	CHEMBL1061212	Percentage ERK8 activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	61.0	CHEMBL5198	Homo sapiens	Activity	%	61.0
	2902123	CHEMBL1061212	Percentage ERK8 activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	92.0	CHEMBL5198	Homo sapiens	Activity	%	92.0
	2902124	CHEMBL1061960	Percentage ERK8 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	82.0	CHEMBL5198	Homo sapiens	Activity	%	82.0
Antagonist	2902125	CHEMBL1061960	Percentage ERK8 activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	7.0	CHEMBL5198	Homo sapiens	Activity	%	7.0
Antagonist	2902126	CHEMBL1061960	Percentage ERK8 activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	28.0	CHEMBL5198	Homo sapiens	Activity	%	28.0
	2902127	CHEMBL1061960	Percentage ERK8 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	70.0	CHEMBL5198	Homo sapiens	Activity	%	70.0
	2902128	CHEMBL1061960	Percentage ERK8 activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	51.0	CHEMBL5198	Homo sapiens	Activity	%	51.0
Antagonist	2902129	CHEMBL1061960	Percentage ERK8 activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	38.0	CHEMBL5198	Homo sapiens	Activity	%	38.0
	2902130	CHEMBL1061960	Percentage ERK8 activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	92.0	CHEMBL5198	Homo sapiens	Activity	%	92.0
	2902131	CHEMBL1052076	Percentage ERK8 activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	94.0	CHEMBL5198	Homo sapiens	Activity	%	94.0
	2902132	CHEMBL1052076	Percentage ERK8 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	67.0	CHEMBL5198	Homo sapiens	Activity	%	67.0
Antagonist	2902133	CHEMBL1052076	Percentage ERK8 activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	37.0	CHEMBL5198	Homo sapiens	Activity	%	37.0
Antagonist	2902134	CHEMBL1052076	Percentage ERK8 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	19.0	CHEMBL5198	Homo sapiens	Activity	%	19.0
	2902135	CHEMBL1052076	Percentage ERK8 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	80.0	CHEMBL5198	Homo sapiens	Activity	%	80.0
	2902136	CHEMBL1052076	Percentage ERK8 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	56.0	CHEMBL5198	Homo sapiens	Activity	%	56.0
	2902137	CHEMBL1052076	Percentage ERK8 activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	70.0	CHEMBL5198	Homo sapiens	Activity	%	70.0
Antagonist	2902138	CHEMBL1052076	Percentage ERK8 activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	12.0	CHEMBL5198	Homo sapiens	Activity	%	12.0
	2902139	CHEMBL1052076	Percentage ERK8 activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	78.0	CHEMBL5198	Homo sapiens	Activity	%	78.0
	2902140	CHEMBL1052076	Percentage ERK8 activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	79.0	CHEMBL5198	Homo sapiens	Activity	%	79.0
Antagonist	2902141	CHEMBL1052076	Percentage ERK8 activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	13.0	CHEMBL5198	Homo sapiens	Activity	%	13.0
	2902142	CHEMBL1052076	Percentage ERK8 activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	79.0	CHEMBL5198	Homo sapiens	Activity	%	79.0
	2902143	CHEMBL1052076	Percentage ERK8 activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	71.0	CHEMBL5198	Homo sapiens	Activity	%	71.0
	2902144	CHEMBL1052076	Percentage ERK8 activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	94.0	CHEMBL5198	Homo sapiens	Activity	%	94.0
Antagonist	2902145	CHEMBL1052076	Percentage ERK8 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	47.0	CHEMBL5198	Homo sapiens	Activity	%	47.0
	2902146	CHEMBL1052076	Percentage ERK8 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	59.0	CHEMBL5198	Homo sapiens	Activity	%	59.0
Antagonist	2902147	CHEMBL1052076	Percentage ERK8 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	49.0	CHEMBL5198	Homo sapiens	Activity	%	49.0
	2902148	CHEMBL1052076	Percentage ERK8 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	88.0	CHEMBL5198	Homo sapiens	Activity	%	88.0
Antagonist	2902149	CHEMBL1052076	Percentage ERK8 activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	7.0	CHEMBL5198	Homo sapiens	Activity	%	7.0
	2902150	CHEMBL1052076	Percentage ERK8 activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	89.0	CHEMBL5198	Homo sapiens	Activity	%	89.0
Antagonist	2902151	CHEMBL1052076	Percentage ERK8 activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	42.0	CHEMBL5198	Homo sapiens	Activity	%	42.0
	2902152	CHEMBL1052076	Percentage ERK8 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	104.0	CHEMBL5198	Homo sapiens	Activity	%	104.0
	2902153	CHEMBL1052076	Percentage ERK8 activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	67.0	CHEMBL5198	Homo sapiens	Activity	%	67.0
	2902154	CHEMBL1052076	Percentage ERK8 activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	71.0	CHEMBL5198	Homo sapiens	Activity	%	71.0
	2902155	CHEMBL1060116	Percentage ERK8 activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	68.0	CHEMBL5198	Homo sapiens	Activity	%	68.0
Antagonist	2902156	CHEMBL1060116	Percentage ERK8 activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	29.0	CHEMBL5198	Homo sapiens	Activity	%	29.0
Antagonist	2902157	CHEMBL1060117	Percentage ERK8 activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	12.0	CHEMBL5198	Homo sapiens	Activity	%	12.0
	2902158	CHEMBL1061213	Percentage ERK8 activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	58.0	CHEMBL5198	Homo sapiens	Activity	%	58.0
	2902159	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	95.0	CHEMBL5198	Homo sapiens	Activity	%	95.0
	2902160	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	91.0	CHEMBL5198	Homo sapiens	Activity	%	91.0
	2902161	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	74.0	CHEMBL5198	Homo sapiens	Activity	%	74.0
	2902162	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	57.0	CHEMBL5198	Homo sapiens	Activity	%	57.0
	2902163	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	93.0	CHEMBL5198	Homo sapiens	Activity	%	93.0
	2902164	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	51.0	CHEMBL5198	Homo sapiens	Activity	%	51.0
	2902165	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	86.0	CHEMBL5198	Homo sapiens	Activity	%	86.0
	2902166	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	93.0	CHEMBL5198	Homo sapiens	Activity	%	93.0
	2902167	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	106.0	CHEMBL5198	Homo sapiens	Activity	%	106.0
	2902168	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	98.0	CHEMBL5198	Homo sapiens	Activity	%	98.0
Antagonist	2902169	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	40.0	CHEMBL5198	Homo sapiens	Activity	%	40.0
	2902170	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	87.0	CHEMBL5198	Homo sapiens	Activity	%	87.0
	2902171	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	75.0	CHEMBL5198	Homo sapiens	Activity	%	75.0
Antagonist	2902172	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	19.0	CHEMBL5198	Homo sapiens	Activity	%	19.0
Antagonist	2902173	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	43.0	CHEMBL5198	Homo sapiens	Activity	%	43.0
Antagonist	2902174	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	48.0	CHEMBL5198	Homo sapiens	Activity	%	48.0
	2902175	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	80.0	CHEMBL5198	Homo sapiens	Activity	%	80.0
	2902176	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	62.0	CHEMBL5198	Homo sapiens	Activity	%	62.0
	2902177	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	70.0	CHEMBL5198	Homo sapiens	Activity	%	70.0
Antagonist	2902178	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	44.0	CHEMBL5198	Homo sapiens	Activity	%	44.0
	2902179	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	68.0	CHEMBL5198	Homo sapiens	Activity	%	68.0
	2902180	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	93.0	CHEMBL5198	Homo sapiens	Activity	%	93.0
	2902181	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	104.0	CHEMBL5198	Homo sapiens	Activity	%	104.0
Antagonist	2902182	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	9.0	CHEMBL5198	Homo sapiens	Activity	%	9.0
	2902183	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	81.0	CHEMBL5198	Homo sapiens	Activity	%	81.0
	2902184	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	107.0	CHEMBL5198	Homo sapiens	Activity	%	107.0
	2902185	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	77.0	CHEMBL5198	Homo sapiens	Activity	%	77.0
	2902186	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	97.0	CHEMBL5198	Homo sapiens	Activity	%	97.0
	2902187	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	66.0	CHEMBL5198	Homo sapiens	Activity	%	66.0
Antagonist	2902188	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	22.0	CHEMBL5198	Homo sapiens	Activity	%	22.0
	2902189	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	82.0	CHEMBL5198	Homo sapiens	Activity	%	82.0
	2902190	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	97.0	CHEMBL5198	Homo sapiens	Activity	%	97.0
	2902191	CHEMBL1062012	Percentage ERK8 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	94.0	CHEMBL5198	Homo sapiens	Activity	%	94.0
	2906218	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	2800.0	CHEMBL5198	Homo sapiens	Kd	nM	2800.0
	2906219	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906220	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	94.0	CHEMBL5198	Homo sapiens	Kd	nM	94.0
	2906221	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906222	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	3000.0	CHEMBL5198	Homo sapiens	Kd	nM	3000.0
	2906223	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	120.0	CHEMBL5198	Homo sapiens	Kd	nM	120.0
	2906224	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906225	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906226	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906227	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906228	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906229	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906230	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906231	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906232	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	330.0	CHEMBL5198	Homo sapiens	Kd	nM	330.0
	2906233	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906234	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906235	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906236	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906237	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	1100.0	CHEMBL5198	Homo sapiens	Kd	nM	1100.0
	2906238	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906239	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	88.0	CHEMBL5198	Homo sapiens	Kd	nM	88.0
	2906240	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906241	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906242	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906243	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906244	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906245	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906246	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906247	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906248	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906249	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	46.0	CHEMBL5198	Homo sapiens	Kd	nM	46.0
	2906250	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	35.0	CHEMBL5198	Homo sapiens	Kd	nM	35.0
	2906251	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906252	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906253	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906254	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2906255	CHEMBL1060193	Binding constant for ERK8 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	2921341	CHEMBL1053724	Inhibition of ERK8 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	98.0	CHEMBL5198	Homo sapiens	Activity	%	98.0
	2924701	CHEMBL1047336	Inhibition of ERK8 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21		CHEMBL567173	=	Activity	%	47.0	CHEMBL5198	Homo sapiens	Activity	%	47.0
	2924702	CHEMBL1047336	Inhibition of ERK8 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21		CHEMBL584980	=	Activity	%	55.0	CHEMBL5198	Homo sapiens	Activity	%	55.0
	2924703	CHEMBL1047336	Inhibition of ERK8 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12		CHEMBL575754	=	Activity	%	112.0	CHEMBL5198	Homo sapiens	Activity	%	112.0
	2924704	CHEMBL1047336	Inhibition of ERK8 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12		CHEMBL583972	=	Activity	%	20.0	CHEMBL5198	Homo sapiens	Activity	%	20.0
	2926196	CHEMBL1046789	Inhibition of ERK8 assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	109.0	CHEMBL5198	Homo sapiens	Activity	%	109.0
	2926290	CHEMBL1057674	Inhibition of ERK8 assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	97.0	CHEMBL5198	Homo sapiens	Activity	%	97.0
	2998988	CHEMBL1048078	Inhibition of ERK8 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 5 uM ATP	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	84.0	CHEMBL5198	Homo sapiens	Activity	%	84.0
	2999778	CHEMBL1048078	Inhibition of ERK8 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 5 uM ATP	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	88.0	CHEMBL5198	Homo sapiens	Activity	%	88.0
	2999855	CHEMBL1048100	Inhibition of ERK8 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 5 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Activity	%	83.0	CHEMBL5198	Homo sapiens	Activity	%	83.0
	2999931	CHEMBL1048100	Inhibition of ERK8 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 5 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Activity	%	88.0	CHEMBL5198	Homo sapiens	Activity	%	88.0
	3130816	CHEMBL1073723	Inhibition of ERK8 at 3 to 6 uM relative to control	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	Inhibition	%	50.0	CHEMBL5198	Homo sapiens	INH	%	50.0
	3131753	CHEMBL1065758	Inhibition of ERK8 at 3 uM relative to control	B	NC(=O)c1ccc(NC(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1		CHEMBL600852	>	Inhibition	%	50.0	CHEMBL5198	Homo sapiens	INH	%	50.0
	3203252	CHEMBL1102992	Inhibition of ERK8	B	Cn1cc(C2=C(c3cccc(NCC(O)CO)c3)C(=O)NC2=O)c2cc(F)ccc21		CHEMBL1082152	=	Kd	nM	32.0	CHEMBL5198	Homo sapiens	Kd	uM	0.032
	3260045	CHEMBL1104346	Inhibition of ERK8 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	85.0	CHEMBL5198	Homo sapiens	Activity	%	85.0
	3261428	CHEMBL1104346	Inhibition of ERK8 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	78.0	CHEMBL5198	Homo sapiens	Activity	%	78.0
	3306917	CHEMBL1117942	Inhibition of ERK8 at 3 uM	B	O=C(Nc1cc2cc[nH]c(=O)c2cc1Cl)C(NC1CC1)c1ccccc1		CHEMBL1084106	=	Inhibition	%	54.0	CHEMBL5198	Homo sapiens	INH	%	54.0
	3331936	CHEMBL1169226	Inhibition of ERK8 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL5198	Homo sapiens	INH	%	50.0
	3333351	CHEMBL1169226	Inhibition of ERK8 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL5198	Homo sapiens	INH	%	50.0
	3334756	CHEMBL1169226	Inhibition of ERK8 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL5198	Homo sapiens	INH	%	50.0
	3336176	CHEMBL1169226	Inhibition of ERK8 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL5198	Homo sapiens	INH	%	50.0
	3340704	CHEMBL1169226	Inhibition of ERK8 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL5198	Homo sapiens	INH	%	50.0
	3342120	CHEMBL1169226	Inhibition of ERK8 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL5198	Homo sapiens	INH	%	50.0
	3358571	CHEMBL1174416	Inhibition of ERK8 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	1.8	CHEMBL5198	Homo sapiens	INH	%	1.8
	3359013	CHEMBL1174416	Inhibition of ERK8 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	2.6	CHEMBL5198	Homo sapiens	INH	%	2.6
	3444979	CHEMBL1244833	Binding affinity to ERK8	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	270.0	CHEMBL5198	Homo sapiens	Kd	nM	270.0
	3445111	CHEMBL1244833	Binding affinity to ERK8	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	4.9	CHEMBL5198	Homo sapiens	Kd	nM	4.9
	3448429	CHEMBL1244833	Binding affinity to ERK8	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	3448753	CHEMBL1244833	Binding affinity to ERK8	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	3449169	CHEMBL1244833	Binding affinity to ERK8	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	46.0	CHEMBL5198	Homo sapiens	Kd	nM	46.0
	3450341	CHEMBL1244833	Binding affinity to ERK8	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	3450998	CHEMBL1244833	Binding affinity to ERK8	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	5133708	CHEMBL1648704	Inhibition of ERK8 assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	78.0	CHEMBL5198	Homo sapiens	Activity	%	78.0
	5133803	CHEMBL1648704	Inhibition of ERK8 assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	75.0	CHEMBL5198	Homo sapiens	Activity	%	75.0
	5133868	CHEMBL1648704	Inhibition of ERK8 assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	72.0	CHEMBL5198	Homo sapiens	Activity	%	72.0
	5191345	CHEMBL1663974	Inhibition of ERK8 at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	Inhibition	%	47.0	CHEMBL5198	Homo sapiens	INH	%	47.0
	5191346	CHEMBL1663974	Inhibition of ERK8 at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	90.0	CHEMBL5198	Homo sapiens	INH	%	90.0
	6183803	CHEMBL1772049	Binding affinity to human Erk8 	B	Cc1nc(CN(C)c2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)cs1		CHEMBL1474834	=	Kd	nM	430.0	CHEMBL5198	Homo sapiens	Kd	nM	430.0
	6273836	CHEMBL1806008	Inhibition of ERK8 assessed as residual enzyme activity at 10 uM	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	Activity	%	26.0	CHEMBL5198	Homo sapiens	Activity	%	26.0
	6274549	CHEMBL1806345	Inhibition of ERK8 at 10 umol/L	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	Inhibition	%	74.0	CHEMBL5198	Homo sapiens	INH	%	74.0
	6274559	CHEMBL1806346	Inhibition of ERK8	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	IC50	nM	330.0	CHEMBL5198	Homo sapiens	IC50	nmol/L	330.0
	6296167	CHEMBL1811062	Inhibition of ERK8 at 1 uM	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1		CHEMBL1809044	>	Inhibition	%	80.0	CHEMBL5198	Homo sapiens	INH	%	80.0
	6339884	CHEMBL1826083	Activity of ERK8 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	17.0	CHEMBL5198	Homo sapiens	Activity	%	17.0
	6352208	CHEMBL1825745	Inhibition of ERK8 assessed as residual activity at 10 uM by radioactivity assay in presence of 5 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	17.0	CHEMBL5198	Homo sapiens	Activity	%	17.0
	7567120	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7567579	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7568050	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7568518	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7568950	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7569093	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7569553	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7570025	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7570488	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7570915	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7571069	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7571526	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7572002	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7573050	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7573507	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7573983	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7574010	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7574418	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	210.0	CHEMBL5198	Homo sapiens	Kd	nM	210.0
	7575028	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7575489	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7575983	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7576391	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7577002	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7577497	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7577967	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7578372	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	510.0	CHEMBL5198	Homo sapiens	Kd	nM	510.0
	7579392	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	73.0	CHEMBL5198	Homo sapiens	Kd	nM	73.0
	7579866	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	1100.0	CHEMBL5198	Homo sapiens	Kd	nM	1100.0
	7580335	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7580738	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7580926	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	89.0	CHEMBL5198	Homo sapiens	Kd	nM	89.0
	7581311	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	3000.0	CHEMBL5198	Homo sapiens	Kd	nM	3000.0
	7581756	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	330.0	CHEMBL5198	Homo sapiens	Kd	nM	330.0
	7582227	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7582691	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7583091	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7583272	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7583669	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Kd	nM	4500.0	CHEMBL5198	Homo sapiens	Kd	nM	4500.0
	7584114	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7584585	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	76.0	CHEMBL5198	Homo sapiens	Kd	nM	76.0
	7585047	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	640.0	CHEMBL5198	Homo sapiens	Kd	nM	640.0
	7585451	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7585602	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	2800.0	CHEMBL5198	Homo sapiens	Kd	nM	2800.0
	7586010	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	120.0	CHEMBL5198	Homo sapiens	Kd	nM	120.0
	7586456	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7586927	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	88.0	CHEMBL5198	Homo sapiens	Kd	nM	88.0
	7587381	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	=	Kd	nM	69.0	CHEMBL5198	Homo sapiens	Kd	nM	69.0
	7587563	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	270.0	CHEMBL5198	Homo sapiens	Kd	nM	270.0
	7587982	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7588435	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7588906	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7589528	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7589952	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	4.9	CHEMBL5198	Homo sapiens	Kd	nM	4.9
	7590419	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7590902	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7591501	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7591923	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7592426	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7592879	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7593468	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	94.0	CHEMBL5198	Homo sapiens	Kd	nM	94.0
	7593903	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7593933	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7594406	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7594858	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7595436	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	=	Kd	nM	120.0	CHEMBL5198	Homo sapiens	Kd	nM	120.0
	7595912	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7596383	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7596830	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	46.0	CHEMBL5198	Homo sapiens	Kd	nM	46.0
	7597419	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7597892	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7598362	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	nM	10000.0
	7598804	CHEMBL1908412	Binding constant for ERK8 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	35.0	CHEMBL5198	Homo sapiens	Kd	nM	35.0
	7969722	CHEMBL1931222	Inhibition of ERK8 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	46.0	CHEMBL5198	Homo sapiens	Activity	%	46.0
	7996687	CHEMBL1944018	Inhibition of ERK8 at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939491	=	Inhibition	%	90.0	CHEMBL5198	Homo sapiens	INH	%	90.0
	10839632	CHEMBL2016260	Inhibition of ERK8 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	47.0	CHEMBL5198	Homo sapiens	Activity	%	47.0
	10839636	CHEMBL2015016	Inhibition of ERK8 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	26.0	CHEMBL5198	Homo sapiens	Activity	%	26.0
	12170810	CHEMBL2210333	Inhibition of ERK8 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	99.0	CHEMBL5198	Homo sapiens	Activity	%	99.0
	12172111	CHEMBL2213937	Inhibition of ERK8 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	99.0	CHEMBL5198	Homo sapiens	Activity	%	99.0
	12173619	CHEMBL2213995	Inhibition of ERK8 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL5198	Homo sapiens	Activity	%	100.0
	12189664	CHEMBL2215621	Binding affinity to T7-phage-tagged MAPK15 by PCR analysis	B	COC(=O)c1c(Cc2ccc(C(=O)NCCO)cc2)c(=O)c2ccc(Cl)cc2n1-c1ccccc1		CHEMBL2152382	>	Kd	nM	10000.0	CHEMBL5198	Homo sapiens	Kd	uM	10.0
	12628458	CHEMBL2321409	Inhibition of ERK8 (unknown origin) at 10 uM	B	N#Cc1c(N)nc2sc(C(=O)c3cccc(Cl)c3)c(N)c2c1-c1ccccc1Cl		CHEMBL2313853	>	Inhibition	%	50.0	CHEMBL5198	Homo sapiens	INH	%	50.0
	12673045	CHEMBL2340164	Inhibition of recombinant ERK8 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	18.0	CHEMBL5198	Homo sapiens	Activity	%	18.0
	12673046	CHEMBL2340164	Inhibition of recombinant ERK8 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	16.0	CHEMBL5198	Homo sapiens	Activity	%	16.0
	13279230	CHEMBL2380166	Inhibition of human ERK7 at 0.1 uM incubated for 15 mins prior to substrate addition measured after 90 mins by P33-radiolabeled assay relative to control	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)sc1C(=O)c1ccccc1[N+](=O)[O-]		CHEMBL2377825	=	Inhibition	%	70.0	CHEMBL5198	Homo sapiens	INH	%	70.0
	13342440	CHEMBL2394168	Competitive binding affinity to ERK8 (unknown origin) assessed as enzyme remaining bound to anchored active-site ligand at 10 uM relative to control	B	Clc1ccc(CNc2nccc(-c3ccc4[nH]ncc4c3)n2)cc1Cl		CHEMBL1892019	<	Activity	%	10.0	CHEMBL5198	Homo sapiens	Activity	%	10.0
	13439847	CHEMBL2427148	Competitive binding affinity to ERK8 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	=	Inhibition	%	91.0	CHEMBL5198	Homo sapiens	INH	%	91.0
	13442423	CHEMBL2427148	Competitive binding affinity to ERK8 (unknown origin) at 10 uM in presence of ATP relative to control	B	CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1		CHEMBL2425628	>	Inhibition	%	85.0	CHEMBL5198	Homo sapiens	INH	%	85.0
	13442496	CHEMBL2429313	Binding affinity to ERK8 (unknown origin)	B	CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1		CHEMBL2425628	=	Kd	nM	650.0	CHEMBL5198	Homo sapiens	Kd	uM	0.65
	13445680	CHEMBL2427148	Competitive binding affinity to ERK8 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	97.0	CHEMBL5198	Homo sapiens	INH	%	97.0
	13451667	CHEMBL2427148	Competitive binding affinity to ERK8 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	99.0	CHEMBL5198	Homo sapiens	INH	%	99.0
	13464310	CHEMBL2432948	Inhibition of human ERK8 in presence of 5 uM ATP	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	IC50	nM	400.0	CHEMBL5198	Homo sapiens	IC50	uM	0.4
	13465524	CHEMBL2434199	Inhibition of human ERK8 assessed as residual activity at 25 uM relative to control	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	68.0	CHEMBL5198	Homo sapiens	Activity	%	68.0
	13465547	CHEMBL2434613	Inhibition of human ERK8 assessed as residual activity at 10 uM relative to control	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	80.0	CHEMBL5198	Homo sapiens	Activity	%	80.0
	13466475	CHEMBL2434226	Inhibition of human ERK8 assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	91.14	CHEMBL5198	Homo sapiens	Activity	%	91.14
	13466502	CHEMBL2434613	Inhibition of human ERK8 assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	89.45	CHEMBL5198	Homo sapiens	Activity	%	89.45
	13466529	CHEMBL2434226	Inhibition of human ERK8 assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	45.29	CHEMBL5198	Homo sapiens	Activity	%	45.29
	13466556	CHEMBL2434613	Inhibition of human ERK8 assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	15.76	CHEMBL5198	Homo sapiens	Activity	%	15.76
	15072484	CHEMBL3379511	Inhibition of ERK8 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	106.0	CHEMBL5198	Homo sapiens	Activity	%	106.0
	15137715	CHEMBL3385160	Inhibition of ERK8 (unknown origin) assessed as residual enzyme activity at 10 uM	B	CO[C@H]1CC[C@H](NC(=O)c2n[nH]cc2NC(=O)c2ccccc2)CC1		CHEMBL3335124	=	Activity	%	14.0	CHEMBL5198	Homo sapiens	Activity	%	14.0
	15137716	CHEMBL3385160	Inhibition of ERK8 (unknown origin) assessed as residual enzyme activity at 10 uM	B	COc1cccc(OC)c1C(=O)Nc1c[nH]nc1C(=O)N[C@H]1CC[C@H](OC)CC1		CHEMBL3335141	=	Activity	%	27.0	CHEMBL5198	Homo sapiens	Activity	%	27.0
	15137717	CHEMBL3385160	Inhibition of ERK8 (unknown origin) assessed as residual enzyme activity at 10 uM	B	CO[C@H]1CC[C@H](NC(=O)c2n[nH]cc2NC(=O)c2ccc(-c3ccccc3)o2)CC1		CHEMBL3335153	=	Activity	%	7.0	CHEMBL5198	Homo sapiens	Activity	%	7.0
	15137718	CHEMBL3385160	Inhibition of ERK8 (unknown origin) assessed as residual enzyme activity at 10 uM	B	COc1cccc(OC)c1C(=O)Nc1c[nH]nc1C(=O)NCc1ccccc1		CHEMBL3335161	=	Activity	%	47.0	CHEMBL5198	Homo sapiens	Activity	%	47.0
	15251799	CHEMBL3427801	Inhibition of ERK8 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	11.0	CHEMBL5198	Homo sapiens	Activity	%	11.0
	15251901	CHEMBL3427801	Inhibition of ERK8 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	15.0	CHEMBL5198	Homo sapiens	Activity	%	15.0
	15251998	CHEMBL3427801	Inhibition of ERK8 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	24.0	CHEMBL5198	Homo sapiens	Activity	%	24.0
	15252643	CHEMBL3427801	Inhibition of ERK8 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	31.0	CHEMBL5198	Homo sapiens	Activity	%	31.0
	15252745	CHEMBL3427801	Inhibition of ERK8 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	54.0	CHEMBL5198	Homo sapiens	Activity	%	54.0
	15252847	CHEMBL3427801	Inhibition of ERK8 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	52.0	CHEMBL5198	Homo sapiens	Activity	%	52.0
	15253521	CHEMBL3427801	Inhibition of ERK8 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	23.0	CHEMBL5198	Homo sapiens	Activity	%	23.0
	15253623	CHEMBL3427801	Inhibition of ERK8 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	24.0	CHEMBL5198	Homo sapiens	Activity	%	24.0
	15253725	CHEMBL3427801	Inhibition of ERK8 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	19.0	CHEMBL5198	Homo sapiens	Activity	%	19.0
	15254391	CHEMBL3427801	Inhibition of ERK8 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	12.0	CHEMBL5198	Homo sapiens	Activity	%	12.0
	15254493	CHEMBL3427801	Inhibition of ERK8 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	18.0	CHEMBL5198	Homo sapiens	Activity	%	18.0
	15254595	CHEMBL3427801	Inhibition of ERK8 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	11.0	CHEMBL5198	Homo sapiens	Activity	%	11.0
	15255286	CHEMBL3427801	Inhibition of ERK8 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	15.0	CHEMBL5198	Homo sapiens	Activity	%	15.0
	15255388	CHEMBL3427801	Inhibition of ERK8 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	19.0	CHEMBL5198	Homo sapiens	Activity	%	19.0
	15255491	CHEMBL3427801	Inhibition of ERK8 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	24.0	CHEMBL5198	Homo sapiens	Activity	%	24.0
	15256222	CHEMBL3427801	Inhibition of ERK8 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	30.0	CHEMBL5198	Homo sapiens	Activity	%	30.0
	15728400	CHEMBL3624241	Inhibition of ERK8 (unknown origin) at 10 uM	B	COc1ccc(-c2cnccc2-c2cnc(NC(=O)C(C)C)s2)c(C(F)(F)F)c1		CHEMBL3623443	>	Inhibition	%	90.0	CHEMBL5198	Homo sapiens	INH	%	90.0
	15756991	CHEMBL3630492	Inhibition of ERK7 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	99.77	CHEMBL5198	Homo sapiens	INH	%	99.77
	15757732	CHEMBL3630492	Inhibition of ERK7 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	87.03	CHEMBL5198	Homo sapiens	INH	%	87.03
	15758711	CHEMBL3630492	Inhibition of ERK7 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	0.89	CHEMBL5198	Homo sapiens	INH	%	0.89
	16431828	CHEMBL3748182	Inhibition of human ERK7 using MBP as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL5198	Homo sapiens	IC50	uM	10.0
	16596823	CHEMBL3812028	Inhibition of human MAPK15 assessed as remaining enzyme activity at 1 uM by KINOMEscan assay	B	Cc1nc2cccc3c2nc1N[C@H](C)/C=C\C[C@H]1CNC(=O)c2cc-3[nH]c21		CHEMBL3809691	<	Activity	%	10.0	CHEMBL5198	Homo sapiens	Activity	%	10.0
	16654177	CHEMBL3830958	Inhibition of human ERK8 (2 to 544 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	19.0	CHEMBL5198	Homo sapiens	Activity	%	19.0
	16777164	CHEMBL3864826	Competitive binding affinity to partial length wild type human ERK8 expressed in bacterial expression system at 10 uM by kinomescan method relative to control	B	C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1		CHEMBL3942186	=	Activity	%	0.65	CHEMBL5198	Homo sapiens	Activity	%	0.65
Inactive	17915442	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915443	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17915444	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	Kd	nM	263.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	263.0
Inactive	17915445	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915446	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915447	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915448	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915449	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915450	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915451	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17915452	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	1205.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	1205.0
Inactive	17915453	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915454	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915455	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915456	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915457	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915458	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915459	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915460	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915461	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915462	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915463	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915464	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915465	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915466	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915467	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915468	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915469	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915470	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915471	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915472	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915473	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915474	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Active	17915475	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	167.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	167.0
Inactive	17915476	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915477	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915478	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915479	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915480	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915481	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915482	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915483	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915484	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915485	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915486	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915487	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915488	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915489	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Active	17915490	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	90.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	90.0
Inactive	17915491	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915492	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915493	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915494	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915495	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915496	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915497	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915498	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915499	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915500	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915501	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915502	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915503	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915504	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17915505	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Kd	nM	1466.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	1466.0
Inactive	17915506	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915507	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915508	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915509	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915510	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915511	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915512	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915513	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915514	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915515	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915516	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915517	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915518	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915519	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915520	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915521	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915522	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915523	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915524	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915525	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915526	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915527	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915528	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915529	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915530	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915531	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915532	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915533	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915534	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915535	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915536	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915537	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915538	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915539	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915540	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915541	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915542	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915543	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915544	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915545	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Active	17915546	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	=	Kd	nM	276.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	276.0
Inactive	17915547	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915548	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915549	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915550	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915551	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915552	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915553	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915554	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915555	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915556	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915557	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915558	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915559	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915560	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915561	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915562	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915563	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915564	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915565	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915566	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915567	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915568	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915569	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915570	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17915571	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	=	Kd	nM	18.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	18.0
Inactive	17915572	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915573	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915574	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915575	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915576	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915577	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915578	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915579	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915580	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915581	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915582	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915583	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915584	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915585	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915586	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915587	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915588	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915589	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915590	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915591	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915592	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915593	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915594	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915595	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915596	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915597	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915598	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915599	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915600	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915601	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915602	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915603	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915604	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915605	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915606	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915607	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915608	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915609	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915610	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915611	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915612	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915613	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915614	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915615	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915616	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915617	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915618	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915619	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915620	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915621	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915622	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915623	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915624	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915625	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915626	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915627	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915628	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915629	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915630	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915631	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915632	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915633	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915634	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915635	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915636	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915637	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915638	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915639	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915640	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915641	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915642	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915643	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915644	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915645	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915646	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915647	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915648	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915649	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915650	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915651	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915652	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915653	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Active	17915654	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	=	Kd	nM	1073.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	1073.0
Inactive	17915655	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915656	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915657	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915658	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915659	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915660	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915661	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915662	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915663	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915664	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915665	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915666	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915667	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915668	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915669	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915670	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915671	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915672	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Active	17915673	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	=	Kd	nM	264.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	264.0
Inactive	17915674	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915675	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915676	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915677	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915678	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915679	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915680	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915681	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915682	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915683	CHEMBL3991773	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL5198	Homo sapiens	Kd apparent	nM	30000.0
	18114360	CHEMBL4025134	Inhibition of wild-type human partial length ERK8 (M1 to P437 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL5198	Homo sapiens	Activity	%	100.0
	18203658	CHEMBL4043945	Inhibition of wild-type human partial length ERK8 (M1 to P437 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL5198	Homo sapiens	Activity	%	100.0
	18232213	CHEMBL4050293	Inhibition of human ERK8 assessed as residual activity at 1 uM in presence of 33P-ATP by filter-binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	10.0	CHEMBL5198	Homo sapiens	Activity	%	10.0
	18253807	CHEMBL4055188	Inhibition of wild-type human partial length ERK7 (M1 to P437 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL5198	Homo sapiens	Activity	%	100.0
	18253808	CHEMBL4055188	Inhibition of wild-type human partial length ERK7 (M1 to P437 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL5198	Homo sapiens	Activity	%	100.0
	18379916	CHEMBL4145817	Inhibition of MAPK15 (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	Inhibition	%	0.23	CHEMBL5198	Homo sapiens	INH	%	0.23
	18379968	CHEMBL4145869	Inhibition of MAPK15 (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	7.3	CHEMBL5198	Homo sapiens	IC50	nM	7.3
	18432406	CHEMBL4155906	Inhibition of human ERK7 at 0.123 uM by Hotspot assay	B	CN1CCN(Cc2ccc(NC(=O)c3n[nH]cc3Nc3ncnc4sccc34)cc2)CC1		CHEMBL4075720	<	IC50	nM	10.0	CHEMBL5198	Homo sapiens	IC50	nM	10.0
	18440200	CHEMBL4157024	Binding affinity to wild-type human partial length ERK8 (M1 to P437 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL5198	Homo sapiens	Activity	%	100.0
	18449817	CHEMBL4178054	Inhibition of human ERK8 (2 to 544 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	123.0	CHEMBL5198	Homo sapiens	Activity	%	123.0
	18484640	CHEMBL4185803	Binding affinity to wild-type human partial length ERK8 (M1 to P437 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	94.0	CHEMBL5198	Homo sapiens	Activity	%	94.0
	18484977	CHEMBL4185803	Binding affinity to wild-type human partial length ERK8 (M1 to P437 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	96.0	CHEMBL5198	Homo sapiens	Activity	%	96.0
	18531732	CHEMBL4195506	Inhibition of wild-type human partial length ERK8 (M1 to P437 residues) expressed in bacterial expression system assessed as residual activity at 20 uM by Kinomescan method relative to control	B	O=C(NNC(=O)c1csc(-c2ccc(Cl)cc2Cl)n1)c1ccccn1		CHEMBL4213787	=	Activity	%	44.0	CHEMBL5198	Homo sapiens	Activity	%	44.0
	18655532	CHEMBL4230703	Binding affinity to wild-type human partial length ERK8 (M1 to P437 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	71.0	CHEMBL5198	Homo sapiens	Activity	%	71.0
	18751611	CHEMBL4264292	Binding affinity to wild-type human partial length ERK8 (M1 to P437 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	86.0	CHEMBL5198	Homo sapiens	Activity	%	86.0
	18857961	CHEMBL4307807	Binding affinity to wild-type human partial length ERK8 (M1 to P437 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	95.0	CHEMBL5198	Homo sapiens	Activity	%	95.0
	18919398	CHEMBL4322758	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged MAPK15 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	113.0	CHEMBL5198	Homo sapiens	Kd	nM	113.0
	18919586	CHEMBL4322758	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged MAPK15 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	306.0	CHEMBL5198	Homo sapiens	Kd	nM	306.0
	18924787	CHEMBL4324298	Binding affinity to recombinant human N-terminal 4xFLAG-tagged/C-terminal His8-fused ERK7 N-terminal domain (M1 to R354 residues) expressed in Sf9 insect cells	B	COC[C@H]1Cn2cc(-c3nc(Nc4ccnn4C)ncc3C)nc2C(=O)N1Cc1ccc(F)c(F)c1		CHEMBL4482864	=	Activity	uM	0.03	CHEMBL5198	Homo sapiens	Activity	uM	0.03
	18924809	CHEMBL4324322	Inhibition of recombinant human N-terminal 4xFLAG-tagged/C-terminal His8-fused ERK7 N-terminal domain (M1 to R354 residues) expressed in Sf9 insect cells at 1 uM relative to control	B	COC[C@H]1Cn2cc(-c3nc(Nc4ccnn4C)ncc3C)nc2C(=O)N1Cc1ccc(F)c(F)c1		CHEMBL4482864	=	Inhibition	%	99.0	CHEMBL5198	Homo sapiens	INH	%	99.0
	18937917	CHEMBL4327689	Inhibition of human ERK7 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	100.94	CHEMBL5198	Homo sapiens	Activity	%	100.94
	18937918	CHEMBL4327689	Inhibition of human ERK7 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	95.03	CHEMBL5198	Homo sapiens	Activity	%	95.03
	18938529	CHEMBL4328049	Inhibition of human ERK7 assessed as residual activity at 100 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL5198	Homo sapiens	Activity	%	65.0
	18938907	CHEMBL4328413	Inhibition of human ERK7 using MBP as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	8.01	CHEMBL5198	Homo sapiens	IC50	10'-9M	8.01
	18958878	CHEMBL4333397	Binding affinity to wild-type human partial length ERK8 (M1 to P437 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	82.0	CHEMBL5198	Homo sapiens	Activity	%	82.0
	18975929	CHEMBL4338188	Inhibition of ERK8 (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]c(I)c(-c3cnc(-c4ccc[nH]4)o3)c12		CHEMBL4548361	>	IC50	nM	10000.0	CHEMBL5198	Homo sapiens	IC50	uM	10.0
	18975930	CHEMBL4338188	Inhibition of ERK8 (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]cc(-c3cnc(-c4cc(Br)c[nH]4)o3)c12		CHEMBL4476426	>	IC50	nM	10000.0	CHEMBL5198	Homo sapiens	IC50	uM	10.0
	18975931	CHEMBL4338188	Inhibition of ERK8 (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]cc(-c3cnc(-c4ccc[nH]4)o3)c12		CHEMBL4446434	=	IC50	nM	46000.0	CHEMBL5198	Homo sapiens	IC50	uM	46.0
	18975932	CHEMBL4338188	Inhibition of ERK8 (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br		CHEMBL4564337	=	IC50	nM	1000.0	CHEMBL5198	Homo sapiens	IC50	uM	1.0
	18975933	CHEMBL4338188	Inhibition of ERK8 (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]cc(-c3cnc(-c4ccc(Br)[nH]4)o3)c12		CHEMBL4475097	>	IC50	nM	10000.0	CHEMBL5198	Homo sapiens	IC50	uM	10.0
	18975934	CHEMBL4338188	Inhibition of ERK8 (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]cc(-c3oc(-c4ccc[nH]4)nc3I)c12		CHEMBL4555884	>	IC50	nM	10000.0	CHEMBL5198	Homo sapiens	IC50	uM	10.0
	18976055	CHEMBL4338203	Inhibition of ERK8 (unknown origin) assessed as residual enzyme activity at 50 uM by [33P]-ATP filter binding kinase assay relative to control	B	COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br		CHEMBL4564337	=	Activity	%	9.0	CHEMBL5198	Homo sapiens	Activity	%	9.0
	18976080	CHEMBL4338227	Binding affinity to wild-type human partial length ERK8 (M1 to P437 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by active-site directed competition binding assay based Kinomescan method relative to control	B	COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br		CHEMBL4564337	=	Activity	%	67.0	CHEMBL5198	Homo sapiens	Activity	%	67.0
	18989090	CHEMBL4340740	Inhibition of recombinant human N-terminal 4xFLAG-tagged/C-terminal His8-fused ERK7 N-terminal domain (M1 to R354 residues) expressed in Sf9 insect cells using RBER-CHKtide as substrate measured after 60 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	CN(CCc1ccc(-c2ccccc2)cc1)Cc1cn(C)c2ccc(C(=O)Nc3ccc(F)cc3)cc12		CHEMBL4446681	=	IC50	nM	61000.0	CHEMBL5198	Homo sapiens	IC50	uM	61.0
Active	19041107	CHEMBL4352368	Inhibition of human ERK7 at 10 uM using MBP as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL5198	Homo sapiens	INH		
	19059580	CHEMBL4357881	Binding affinity to wild-type human partial length ERK8 (M1 to P437 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL5198	Homo sapiens	Activity	%	100.0
	19090151	CHEMBL4365725	Inhibition of wild-type human partial length ERK8 (M1 to P437 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	76.0	CHEMBL5198	Homo sapiens	Activity	%	76.0
	19091922	CHEMBL4366396	Inhibition of human ERK7 at 100 nM using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-4.54	CHEMBL5198	Homo sapiens	INH	%	-4.54
	19133352	CHEMBL4375340	Binding affinity to wild-type human partial length ERK8 (M1 to P437 residues) expressed in bacterial expression system measured after 1 hr by kinomescan method	B	O=C(Nc1ccc2cc(C(=O)Nc3nccs3)ccc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL4445812	=	Kd	nM	5320.0	CHEMBL5198	Homo sapiens	Kd	uM	5.32
	19159408	CHEMBL4382512	Binding affinity to wild-type human partial length ERK8 (M1 to P437 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	73.0	CHEMBL5198	Homo sapiens	Activity	%	73.0
	19191599	CHEMBL4389231	Inhibition of wild-type human partial length ERK8 (M1 to P437 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	99.0	CHEMBL5198	Homo sapiens	INH	%	99.0
	19191894	CHEMBL4389708	Inhibition of wild-type human partial length ERK8 (M1 to P437 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	81.0	CHEMBL5198	Homo sapiens	INH	%	81.0
	19199888	CHEMBL4391334	Binding affinity to wild-type human partial length ERK8 (M1 to P437 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	0.05	CHEMBL5198	Homo sapiens	Activity	%	0.05
	19266418	CHEMBL4405368	Inhibition of wild-type human partial length ERK8 (M1 to P437 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL5198	Homo sapiens	INH	%	50.0
	22421635	CHEMBL4673637	Inhibition of human ERK8 (2 to 544 residues) at 10 uM incubated for 5 mins in presence of [gamma33P]ATP by scintillation counting analysis relative to control	B	O=C(Cc1ccc(F)c(F)c1)N1CCC(Nc2ncc3c(N4CCOCC4)n[nH]c3n2)CC1		CHEMBL4762609	>	Inhibition	%	40.0	CHEMBL5198	Homo sapiens	INH	%	40.0
	22421639	CHEMBL4673641	Inhibition of human ERK8 (2 to 544 residues) incubated for 5 mins in presence of [gamma33P]ATP by scintillation counting analysis	B	O=C(Cc1ccc(F)c(F)c1)N1CCC(Nc2ncc3c(N4CCOCC4)n[nH]c3n2)CC1		CHEMBL4762609	=	IC50	nM	110.0	CHEMBL5198	Homo sapiens	IC50	uM	0.11
	22423627	CHEMBL4674389	Inhibition of human ERK7 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	91.15	CHEMBL5198	Homo sapiens	Activity	%	91.15
	22423628	CHEMBL4674389	Inhibition of human ERK7 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	57.67	CHEMBL5198	Homo sapiens	Activity	%	57.67
	22441936	CHEMBL4678870	Inhibition of human recombinant N-terminal FLAG-tagged ERK7 expressed in Sf9 insect cells at 0.1 uM incubated for 60 mins by TR-FRET based LanthaScreen Eu kinase binding assay relative to control	B	CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1		CHEMBL4462530	=	Inhibition	%	83.0	CHEMBL5198	Homo sapiens	INH	%	83.0
	22843751	CHEMBL4720737	Inhibition of human ERK7 using MBP as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	9.1	CHEMBL5198	Homo sapiens	IC50	10^-9M	9.1
	22844103	CHEMBL4721089	Inhibition of human ERK7 assessed as residual activity using MBP as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	96.4	CHEMBL5198	Homo sapiens	Activity	%	96.4
	22844705	CHEMBL4721380	Inhibition of ERK7 (unknown origin) assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	98.95	CHEMBL5198	Homo sapiens	Activity	%	98.95
	22915574	CHEMBL4735376	Inhibition of wild-type human partial length ERK8 (M1 to P437 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	A	O=c1ccc(-c2ccc3cn[nH]c3c2)cn1Cc1ccccc1		CHEMBL4789590	=	Activity	%	20.0	CHEMBL5198	Homo sapiens	Activity	%	20.0
	22915575	CHEMBL4735376	Inhibition of wild-type human partial length ERK8 (M1 to P437 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	A	Nc1n[nH]c2cc(-c3ccc(=O)n(Cc4ccccc4F)c3)ccc12		CHEMBL4752141	=	Activity	%	25.0	CHEMBL5198	Homo sapiens	Activity	%	25.0
	22915576	CHEMBL4735376	Inhibition of wild-type human partial length ERK8 (M1 to P437 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	A	Nc1n[nH]c2cc(-c3ccc(=O)n(Cc4cccc(Cl)c4)c3)ccc12		CHEMBL4764756	=	Activity	%	5.7	CHEMBL5198	Homo sapiens	Activity	%	5.7
	22974458	CHEMBL4771296	Binding affinity to wild-type human partial length ERK8 (M1 to P437 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	O=C(Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL4792974	<	Activity	%	35.0	CHEMBL5198	Homo sapiens	Activity	%	35.0
	23122566	CHEMBL4804917	Inhibition of human ERK8 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	76.0	CHEMBL5198	Homo sapiens	Activity	%	76.0
	23123261	CHEMBL4805505	Inhibition of human ERK8 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	83.0	CHEMBL5198	Homo sapiens	Activity	%	83.0
	23123630	CHEMBL4805874	Inhibition of DNA-tagged human ERK8 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	96.0	CHEMBL5198	Homo sapiens	Activity	%	96.0
	23124259	CHEMBL4806332	Inhibition of ERK7 (unknown origin) at 10 uM relative to control	B	Cn1cc(-n2cnc3c(NCc4nc5cc(Cl)c(Cl)cc5[nH]4)nc(N4CCOCC4)nc32)cn1		CHEMBL4877117	=	Inhibition	%	0.0	CHEMBL5198	Homo sapiens	INH	%	0.0
	23124612	CHEMBL4806522	Inhibition of human ERK8 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	98.0	CHEMBL5198	Homo sapiens	Activity	%	98.0
	23124613	CHEMBL4806522	Inhibition of human ERK8 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	99.0	CHEMBL5198	Homo sapiens	Activity	%	99.0
	23128092	CHEMBL4807839	Inhibition of ERK7 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL5198	Homo sapiens	Activity	%	75.0
	23128093	CHEMBL4807839	Inhibition of ERK7 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL5198	Homo sapiens	Activity	%	75.0
	23128094	CHEMBL4807839	Inhibition of ERK7 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL5198	Homo sapiens	Activity	%	75.0
	23213431	CHEMBL4822965	Inhibition of human recombinant MAPK15 by Lanthascreen assay	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930	=	Inhibition	%	26.0	CHEMBL5198	Homo sapiens	INH	%	26.0
	23233998	CHEMBL4827580	Inhibition of wild-type human partial length ERK8 (M1 to P437 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	O=C(O)c1ccc(-c2c[nH]c3ncccc23)cc1C1CCCC1		CHEMBL4125686	<	Activity	%	10.0	CHEMBL5198	Homo sapiens	Activity	%	10.0
Not Active	23317401	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	95.0	CHEMBL5198	Homo sapiens	% Control	%	95.0
Not Active	23317869	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23318538	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	58.0	CHEMBL5198	Homo sapiens	% Control	%	58.0
Not Active	23319019	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23319656	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23320131	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23320809	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23321277	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	82.0	CHEMBL5198	Homo sapiens	% Control	%	82.0
Not Active	23321907	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23322375	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23323064	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23323532	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23324386	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23325021	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23325489	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23326136	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	68.0	CHEMBL5198	Homo sapiens	% Control	%	68.0
Not Active	23326604	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	65.0	CHEMBL5198	Homo sapiens	% Control	%	65.0
Not Active	23327304	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23327772	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23328359	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23328827	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	56.0	CHEMBL5198	Homo sapiens	% Control	%	56.0
Not Active	23329773	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23330241	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23330997	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23331465	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23332052	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	94.1	CHEMBL5198	Homo sapiens	% Control	%	94.1
Not Active	23332518	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23333236	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23333875	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23334343	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23335322	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23335790	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23336417	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23336885	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23337966	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	91.0	CHEMBL5198	Homo sapiens	% Control	%	91.0
Not Active	23338434	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	96.0	CHEMBL5198	Homo sapiens	% Control	%	96.0
Not Active	23339046	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23339514	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23340151	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23340619	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23341276	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23341744	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23342360	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23342828	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23343458	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23343926	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	98.0	CHEMBL5198	Homo sapiens	% Control	%	98.0
Not Active	23344564	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23345137	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23345605	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23346182	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23346651	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	80.3	CHEMBL5198	Homo sapiens	% Control	%	80.3
Slightly Active	23347572	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	37.1	CHEMBL5198	Homo sapiens	% Control	%	37.1
Not Active	23347573	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174	=	Kd	nM	30.0	CHEMBL5198	Homo sapiens	Kd	nM	30.0
Not Active	23347742	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23348321	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23348789	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23349376	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	94.0	CHEMBL5198	Homo sapiens	% Control	%	94.0
Not Active	23349994	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	78.0	CHEMBL5198	Homo sapiens	% Control	%	78.0
Not Active	23350462	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23351067	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23351535	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23352559	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	81.0	CHEMBL5198	Homo sapiens	% Control	%	81.0
Not Active	23353027	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	72.0	CHEMBL5198	Homo sapiens	% Control	%	72.0
Not Active	23353909	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23354377	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23355109	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23355577	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23356213	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	90.0	CHEMBL5198	Homo sapiens	% Control	%	90.0
Not Active	23356681	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23357290	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	93.0	CHEMBL5198	Homo sapiens	% Control	%	93.0
Not Active	23357937	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	83.0	CHEMBL5198	Homo sapiens	% Control	%	83.0
Not Active	23358405	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23358991	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	82.4	CHEMBL5198	Homo sapiens	% Control	%	82.4
Not Active	23359589	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23360057	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23360642	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	78.0	CHEMBL5198	Homo sapiens	% Control	%	78.0
Not Active	23361110	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	84.0	CHEMBL5198	Homo sapiens	% Control	%	84.0
Not Active	23361683	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	86.0	CHEMBL5198	Homo sapiens	% Control	%	86.0
Not Active	23362219	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	95.0	CHEMBL5198	Homo sapiens	% Control	%	95.0
Not Active	23362687	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23364329	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	85.0	CHEMBL5198	Homo sapiens	% Control	%	85.0
Not Active	23364797	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	94.0	CHEMBL5198	Homo sapiens	% Control	%	94.0
Not Active	23365536	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23366079	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	93.0	CHEMBL5198	Homo sapiens	% Control	%	93.0
Not Active	23366669	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23367137	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23368015	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	93.0	CHEMBL5198	Homo sapiens	% Control	%	93.0
Not Active	23368483	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	94.0	CHEMBL5198	Homo sapiens	% Control	%	94.0
Not Active	23369082	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23369550	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	73.0	CHEMBL5198	Homo sapiens	% Control	%	73.0
Not Active	23370518	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	81.0	CHEMBL5198	Homo sapiens	% Control	%	81.0
Not Active	23370986	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	89.0	CHEMBL5198	Homo sapiens	% Control	%	89.0
Not Active	23371795	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23372263	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
	23372800	CHEMBL4884765	ERK7(MP15LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL5198	Homo sapiens	pIC50		6.0
	23373209	CHEMBL4885056	ERK7(MP15LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL5198	Homo sapiens	pIC50		6.0
	23373568	CHEMBL4885345	ERK7(MP15LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL5198	Homo sapiens	pIC50		6.0
Not Active	23375690	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	96.0	CHEMBL5198	Homo sapiens	% Control	%	96.0
Not Active	23376158	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23376735	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23377204	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23378063	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	74.0	CHEMBL5198	Homo sapiens	% Control	%	74.0
Not Active	23378531	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	93.0	CHEMBL5198	Homo sapiens	% Control	%	93.0
Not Active	23379698	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23380166	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	92.0	CHEMBL5198	Homo sapiens	% Control	%	92.0
Not Active	23380860	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	74.0	CHEMBL5198	Homo sapiens	% Control	%	74.0
Not Active	23381508	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Not Active	23381976	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL5198	Homo sapiens	% Control	%	100.0
Slightly Active	23382600	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	40.0	CHEMBL5198	Homo sapiens	% Control	%	40.0
Active	23383068	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	4.8	CHEMBL5198	Homo sapiens	% Control	%	4.8
Not Active	23383632	CHEMBL4887288	MAPK15 (ERK7) Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	103.0	CHEMBL5198	Homo sapiens	% Ctrl	%	103.0
Not Active	23384038	CHEMBL4887636	ERK8 DUNDEE kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	63.2	CHEMBL5198	Homo sapiens	% Ctrl	%	63.2
Not Active	23384983	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	87.0	CHEMBL5198	Homo sapiens	% Control	%	87.0
Not Active	23385450	CHEMBL4879707	KinomeScan assay: inhibition of ERK8	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	81.0	CHEMBL5198	Homo sapiens	% Control	%	81.0
